Organigram Holdings Inc.'s fiscal second-quarter results missed analyst expectations as the launch of Cannabis 2.0 products resulted in higher costs for the cannabis producer. 

The Moncton, N.B.-based pot producer said its second-quarter revenue was $23.2 million, down from $26.9 million in the same period a year earlier, and down sequentially from $25.2 million in the previous quarter. The decline in revenue was attributed to fewer sales of its traditional dried flower and oil products as well as lower prices amid increased competition in the Canadian recreational market. 

Cannabis stocks are exciting for investors because of the long-term growth prospects in the sector. But investing in pot companies can also be challenging and scary, and there are a lot of potential pitfalls.

Profitability is extremely hard to come by amongst marijuana stocks. With so many companies in the cannabis industry, finding a few that have a chance at seeing profits can be a difficult task.

Sales in P.E.I. Cannabis have fallen close to 70 per cent since retail outlets were closed in order to help stop the spread of COVID-19. 

Cannabis retail stores on the Island were closed alongside liquor stores on March 19. While some liquor stores on the Island have reopened, the cannabis stores remain closed, although sales can still be made online. 

"Right now we're probably doing approximately 30 to 35 per cent of our normal business that we would do during this time of year," said Zach Currie, director of operations with the P.E.I. Cannabis Management Corporation. 

P.E.I. Cannabis has seen a spike in its online orders, said Currie, and that's where staff have been focusing most of their attention. 

Nova Scotia’s provincial government is trying to make it safer for seniors and those vulnerable to COVID-19 to shop for alcohol and cannabis.

The NSLC — Nova Scotia Liquor Corporation that regulates recreational cannabis and liquor sales in the province — is launching designated shopping times for seniors or people who are immunocompromised.

“Starting tomorrow, we’re adjusting our store hours by one hour,” the company tweeted on Sunday. “All stores will be open 10 a.m. to 6 p.m. Mon-Sat. We’ll open an hour earlier to seniors and those at-risk: 10 a.m.–11 a.m. All stores remain closed Sundays. Please respect our precautions. We are all in this together.”

The cannabis movement and research surrounding the plant now have more momentum than at any other point since prohibition began.

The momentum for cannabis reform efforts and also for innovation in cannabis technology, medicine, and science is carrying the industry forward at a rapid pace.

First discovered in the 1960s, Cannabigerol (CBG), a once rare, non-psychoactive molecule from which hundreds of other cannabinoids are derived, recently gained momentum as more companies and brands like Avicanna Inc. AVCNF 0.55% learn of the molecule’s therapeutic benefits in over-the-counter and pharmaceutical applications.

According to recent investigations by Avicanna, CBG has similar properties to CBD, acting as a competitive partial agonist for cannabinoid receptors in the nervous system and immune cells.

According to new data, the week ending March 20, 2020 saw a nearly 67% decrease in merger and acquisition activity versus the same period in 2019.

In 2019, there were over 290 merger and acquisition transactions in the cannabis industry. We’re now over 3 months into 2020 and there have been just 20 so far, leading many investors to questions whether or not the novel coronavirus has killed the marijuana industry’s M&A streak.

Aggressive health measures to stem the spread of the Coronavirus or COVID-19 are changing everything, including the operation of CBD businesses.  And if there’s one thing CBD business owners are accustomed to, it’s change.